Research smoothes collagen peptide woes

The company’s Peptan collagen peptide product is easily digestible, bioactive and has the backing of a growing body of research to support its efficacy, claims Rousselot.
‘Improvements’
“One placebo-controlled clinical study carried out by 100 middle-aged patients with osteoarthritis found that an 8g daily intake of Peptan can significantly reduce knee joint pain and improve mobility,” the company claims.
Peptan is also taste- and odour-free and, as well as being proven to reduce joint pain and improve mobility, it can also support bone health and even improve skin quality.
“Scientific evidence has shown Peptan’s effectiveness in enhancing skin suppleness and preventing the formation of wrinkles,” adds the company.